±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 5380  |  »Ø¸´: 6
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßa253268277½«ÔùËÍÄú 90 ¸ö½ð±Ò

a253268277

ľ³æ (СÓÐÃûÆø)

[ÇóÖú] ¡¾ÇóÖú¸÷λ³æÓÑ¡¿ÈçºÎÏÂÔØÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¾­·ÑÊý¾Ý¿âµÄ±êÊéÄØ ÒÑÓÐ1È˲ÎÓë

¡¾ÇóÖú¸÷λ³æÓÑ¡¿ÈçºÎÏÂÔØÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¾­·ÑÊý¾Ý¿âµÄ±êÊéÄØ
¡¾ÇóÖú¸÷λ³æÓÑ¡¿ÈçºÎÏÂÔØÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¾­·ÑÊý¾Ý¿âµÄ±êÊéÄØ
¡¾ÇóÖú¸÷λ³æÓÑ¡¿ÈçºÎÏÂÔØÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©¾­·ÑÊý¾Ý¿âµÄ±êÊéÄØ
ÀýÈ磺
ÈçºÎÏÂÔØÕâ¸ö±êÊéÈ«ÎÄÄØ£¬½ð±Ò½ð±Ò½ð±ÒËæÒâ

퉀Predictors, consequences, and motivations of benzodiazepine use in patients with chronic obstructive pulmonary disease
±àºÅ£º9466801 ÏîÄ¿ÀàÐÍ£º1F32HL140685-01 µ¥Î»£ºUNIVERSITY OF WASHINGTON
Äê¶È£º2018    ÏîÄ¿½ð¶î£º$75155          ¹ú¼Ò£ºÃÀ¹ú
ÏîÄ¿¸ºÔðÈË£ºDONOVAN, LUCAS MATTHEW;

Symptoms of insomnia and anxiety are common in patients with chronic obstructive pulmonary disease (COPD) and detract from quality of life. These symptoms are further exacerbated in the setting of mental health disorders such as posttraumatic stress disorder (PTSD). Although patients with COPD and comorbid PTSD may experience temporary relief from the use of benzodiazepines, these medications pose significant risks. In patients with COPD, benzodiazepine use is associated with a 45% increased risk of exacerbations, and increased risks for respiratory failure and mortality¡ªalthough our understanding of these risks is incomplete. In patients with PTSD, benzodiazepine use reinforces PTSD symptoms, impairs recovery, and increases the risk of subsequent substance abuse. Given these findings, guidelines have advocated against the routine use of benzodiazepines in patients with either COPD or PTSD, although there may be utility for use in end of life symptom palliation. Despite these recommendations, we found that benzodiazepines are used in 35% of patients with COPD and comorbid PTSD in the Veterans Health Administration (VA). This rate of use is approximately seven times that observed in the general population. We hypothesize that system level factors such as lower center volume, and lower complexity of care provided will be associated with benzodiazepine use after adjustment for patient level factors. Furthermore, as each condition predisposes patients to unique risks related to benzodiazepine use, we hypothesize that the use of benzodiazepines in patients with COPD and comorbid PTSD will result in excess mortality. The current project seeks to test these hypotheses in three aims: 1) identify predictors of chronic benzodiazepine use in a national population of patients with COPD and comorbid PTSD, 2) evaluate mortality risk related to chronic benzodiazepine use in patients with COPD and comorbid PTSD in a propensity matched cohort, and 3) identify patient and provider perspectives regarding the use of benzodiazepine medications to reduce anxiety and insomnia symptoms in patients with COPD and comorbid PTSD. Knowledge of predictors and perspectives regarding benzodiazepine use gained from accomplishing aims 1 and 3 will inform targets for de implementation of guideline inconsistent benzodiazepine use, and knowledge gained from aim 2 will help gauge the potential mortality impact of such an intervention. Future efforts aimed at de implementation will focus on the substitution of alternative agents and education regarding the harms of benzodiazepine use in this setting.

Close
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangtom

гæ (ÖøÃûдÊÖ)

Õâ¸öÄѵÀ»¹¿ÉÒÔÏÂÔØÃ´£¿²»ÊDZ£ÃܵÄÂð£¿Ó¦¸Ã²»ºÃÏÂÔØµÄ°É¡£

·¢×ÔСľ³æAndroid¿Í»§¶Ë
2Â¥2018-07-14 12:43:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÄäÃû

Óû§×¢Ïú (ÕýʽдÊÖ)

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
a253268277: ½ð±Ò+10, ¡ïÓаïÖú 2018-07-17 11:29:54
±¾Ìû½öÂ¥Ö÷¿É¼û
3Â¥2018-07-14 16:50:00
ÒÑÔÄ   ÉêÇëJEPI   »Ø¸´´ËÂ¥   ±à¼­   ²é¿´ÎÒµÄÖ÷Ò³
4Â¥2018-07-14 18:52:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
5Â¥2018-07-14 22:27:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

a253268277

ľ³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
3Â¥: Originally posted by xyq404 at 2018-07-14 16:50:00
»¹ÃÀ¹úµÄ£¬ÖйúµÄÄãÏÂÔØÒ»¸ö¿´¿´¡££¬¡£¡£

ÒѾ­½áÌâµÄÄÜÏÂÔØÂð£¿
6Â¥2018-07-17 11:29:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fishlu77

ľ³æ (СÓÐÃûÆø)

nihÖ»ÄܲéÕªÒª×ÊÖúÊý¶î³É¹ûÄÇЩ°É£¬´Ónih reporterÉÏ¿ÉÒԲ顫µ«ÊÇÈ«ÎÄÊÇ¿´²»µ½µÄ£¡

·¢×ÔСľ³æAndroid¿Í»§¶Ë
7Â¥2018-07-17 15:16:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ a253268277 µÄÖ÷Ìâ¸üÐÂ
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 302·Ö 085601Çóµ÷¼ÁÍÆ¼ö +11 zyxÉϰ¶£¡ 2026-04-05 11/550 2026-04-05 22:13 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸Çà¿Æ085500£¬³õÊÔ295·Ö£¬¹«¹²¿Î213·Ö +3 Óöµ½µÄÈËÔ¸Íû¶¼Ä 2026-04-05 3/150 2026-04-05 18:45 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 083200 333Çóµ÷¼Á +3 Ê®¶þ£¡£¡ 2026-04-04 3/150 2026-04-05 08:28 by barlinike
[¿¼²©] É격 +7 IQwQl 2026-04-04 7/350 2026-04-04 23:32 by mumin1990
[¿¼ÑÐ] 277Çóµ÷¼Á +4 12A3 2026-04-02 5/250 2026-04-04 20:28 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 272Çóµ÷¼Á +4 Ëɰس£Çà5 2026-04-03 4/200 2026-04-04 17:03 by babysonlkd
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 ÎâèùÓ±£¡ 2026-04-03 11/550 2026-04-04 09:56 by ССÊ÷2024
[¿¼ÑÐ] ¿¼ÑÐÇóµ÷¼Á +3 ľÐÄÏë¼ÌÐøÉîÔì 2026-04-03 3/150 2026-04-03 21:56 by à£à£à£0119
[¿¼ÑÐ] Ó¢Ò»ÊýÒ»408£¬×Ü·Ö284£¬¶þÕ½Õæ³ÏÇóµ÷¼Á +13 12.27 2026-03-30 15/750 2026-04-03 14:41 by µªÆøÆøÆø
[¿¼ÑÐ] 282Çóµ÷¼Á ²»Ìôרҵ ÇóÊÕÁô +7 Yam. 2026-03-30 8/400 2026-04-03 14:12 by zhangdingwa
[¿¼ÑÐ] ³õÊԳɼ¨337ÕÒµ÷¼Á +3 ??? ?. ? 2026-04-03 3/150 2026-04-03 11:43 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼Á +8 ÖªÕÑÂû 2026-04-02 8/400 2026-04-03 10:36 by macy2011
[¿¼ÑÐ] 085801 ×Ü·Ö275 ±¾¿ÆÐÂÄÜÔ´ Çóµ÷¼Á +19 bradoner 2026-04-01 23/1150 2026-04-03 10:07 by linyelide
[¿¼ÑÐ] 0703»¯Ñ§ +7 goldtt 2026-04-02 9/450 2026-04-03 09:36 by À¶ÔÆË¼Óê
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ£¬085600£¬344 +7 κ×Óper 2026-04-02 8/400 2026-04-02 21:12 by °ÙÁéͯ888
[¿¼ÑÐ] 26¿¼Ñе÷¼Á +4 Wnz.20030617 2026-04-01 5/250 2026-04-02 16:11 by 1939136013¹·×³
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +8 Ë«ÂíβƦÀϰå2 2026-04-02 9/450 2026-04-02 14:45 by 5896
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +11 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 11/550 2026-04-02 10:52 by lnilvy
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-03-31 11/550 2026-04-01 09:43 by xiayizhi
[¿¼ÑÐ] Çóµ÷¼Á£ºÒ»Ö¾Ô¸£ºÄϾ©´óѧ רҵ£º0705 ×Ü·Ö320 £¬±¾¿Æ985£¬ËÄÁù¼¶Òѹý +3 lfy760306 2026-03-31 3/150 2026-04-01 01:57 by Creta
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û